The Collagen Receptor uPARAP in Malignant Mesothelioma: A Potential Diagnostic Marker and Therapeutic Target
Malignant mesothelioma (MM) is a highly aggressive cancer with limited therapeutic options. We have previously shown that the endocytic collagen receptor, uPARAP, is upregulated in certain cancers and can be therapeutically targeted. Public RNA expression data display uPARAP overexpression in MM. Th...
Guardado en:
Autores principales: | Pınar Çakılkaya, Rikke Raagaard Sørensen, Henrik Jessen Jürgensen, Oliver Krigslund, Henrik Gårdsvoll, Christoffer F. Nielsen, Eric Santoni-Rugiu, Niels Behrendt, Lars H. Engelholm |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bf9c3787659c42d8b0502307136ed2ba |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis
por: Tania Durré, et al.
Publicado: (2018) -
Serum Calretinin as a Biomarker in Malignant Mesothelioma
por: Cita Zupanc, et al.
Publicado: (2021) -
Mesothelioma with Nonbacterial Thrombotic Endocarditis: A Case Report
por: Avatar Verma, et al.
Publicado: (2021) -
A preliminary study: is fibulin 1 a friend or an enemy that needs to be silenced with siRNAs for mesothelioma?
por: Asude Aksoy, et al.
Publicado: (2021) -
Modern management of malignant pleural mesothelioma
por: Patel SC, et al.
Publicado: (2016)